The domestic COVID-19 (coronavirus disease 2019) epidemic has entered a period of rapid growth, and the demand for rapid screening reagents has greatly increased. President Tsai Ing-wen delivered a video today on the epidemic prevention work. She said that the government will continue to increase the supply of rapid screening reagents. , In this month, it is expected to obtain about 100 million doses of rapid screening reagents, and the supply will become more and more stable. Therefore, she would like to ask everyone not to hoard, and not to panic too much, and to use the quick sieve as much as possible when needed.
President Tsai said that the Executive Yuan has also cooperated with the industry to give priority to increasing the convenient channels for shipment to the market in Beibei Kitao, which is currently at a high risk of the epidemic, so that people in these areas can easily buy when they are in urgent need. The stock will be added every week.
President Tsai said that because of the previous stage, we defended very well. The Chinese people did their best to vaccinate and do all kinds of independent epidemic prevention. From the beginning of this year to the present (statistics to 5/5), the confirmed severe disease rate is about 0.03%, causing death. The disease rate is 0.02%, and the moderate disease rate is about 0.22%. The health risk of the epidemic is relatively low. This also means that as long as we are prepared, we can overcome the threat of the epidemic, please don’t panic.
President Tsai also mentioned that he should say “Thank you for your hard work” to every Chinese who takes care of their families. Because of everyone’s hard work, we finally reached this final stage. It is now May 2022. With reference to the experience of other countries’ epidemic development and the estimates of experts, the number of confirmed cases will continue to increase before the epidemic is about to come to an end, but don’t worry.
President Tsai urged the public to pay attention to the latest epidemic prevention information and guidelines in the final stage of the epidemic.
Responsible editor: Yu Weining